List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 114 studies with search of:   Open Studies | Bulgaria
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Conditions: Tumor;   Pain
Interventions: Drug: CG5503 ER;   Drug: Placebo to match CG5503;   Drug: Morphine Sulphate CR;   Drug: Placebo to match Morphine Sulphate CR
2 Recruiting Phase 3 Study to Evaluate Efficacy and Safety of Oxcarbazepine Extended-Release in Subjects With Refractory Partial Seizures Due to Epilepsy When Used With up to 2 Other Antiepileptic Drugs.
Condition: Epilepsy
Interventions: Drug: Placebo;   Drug: Oxcarbazepine Extended Release;   Drug: Oxcarbazepine Extended Release
3 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
4 Recruiting Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
5 Recruiting Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia
Condition: Bacterial Pneumonia
Interventions: Drug: ceftaroline;   Drug: ceftriaxone
6 Not yet recruiting FondaparinUx Trial With UFH During Revascularization in Acute Coronary Syndromes
Conditions: Non ST Segment Elevation Myocardial Infarction;   Unstable Angina;   Acute Coronary Syndrome
Intervention: Drug: Unfractioned heparin
7 Recruiting Long-Term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)
Conditions: Multiple Sclerosis;   Clinically Isolated Syndrome
Interventions: Drug: RNF;   Drug: RNF;   Drug: RNF;   Drug: Rebif® New Formulation (RNF)
8 Recruiting RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure;   Anemia;   Cardiovascular Disease;   Ventricular Dysfunction;   Congestive Heart Failure
Interventions: Drug: Darbepoetin alfa;   Drug: Placebo
9 Recruiting BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Condition: Multiple Sclerosis
Interventions: Drug: laquinimod;   Drug: placebo;   Drug: Interferon β-1a (Avonex®)
10 Recruiting Efficacy and Safety of Lu AA21004 in Acute Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Lu AA21004;   Drug: Lu AA21004;   Drug: Lu AA21004;   Drug: Duloxetine;   Drug: Placebo
11 Recruiting Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer
Condition: Bone Metastases in Men With Hormone-Refractory Prostate Cancer
Interventions: Drug: denosumab;   Drug: zoledronic acid
12 Recruiting Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
13 Recruiting Post-Authorization Safety Study in CKD Subjects Receiving HX575 i.v.
Condition: Chronic Kidney Disease
Intervention: Drug: HX575 recombinant human erythropoietin alfa
14 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder.
Condition: Overactive Bladder
Interventions: Drug: Tolterodine ER;   Drug: Placebo;   Drug: Fesoterodine
15 Recruiting Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Condition: Gastroesophageal Reflux Disease (GERD)
Interventions: Drug: Rabeprazole sodium;   Drug: Esomeprazole
16 Recruiting A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014179)
Condition: Ulcerative Colitis
Interventions: Biological: Placebo;   Biological: Golimumab, placebo;   Biological: golimumab, placebo
17 Recruiting Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin
Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin;   Drug: Placebo
18 Recruiting Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Lurasidone HCl
19 Recruiting Secondary Prevention of Venous Thrombo Embolism.
Condition: Thromboembolism
Intervention: Drug: warfarin
20 Recruiting A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014176)
Condition: Ulcerative Colitis
Interventions: Biological: Placebo;   Biological: Golimumab, placebo;   Biological: Golimumab, placebo;   Biological: Golimumab, placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services